0001042074-15-000001.txt : 20150814 0001042074-15-000001.hdr.sgml : 20150814 20150814120145 ACCESSION NUMBER: 0001042074-15-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150814 DATE AS OF CHANGE: 20150814 EFFECTIVENESS DATE: 20150814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc. CENTRAL INDEX KEY: 0001042074 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943103561 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-245800 FILM NUMBER: 151053900 BUSINESS ADDRESS: STREET 1: 7999 GATEWAY BLVD STREET 2: SUITE 130 CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 510-293-8800 MAIL ADDRESS: STREET 1: 7999 GATEWAY BLVD STREET 2: SUITE 130 CITY: NEWARK STATE: CA ZIP: 94560 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX, INC. DATE OF NAME CHANGE: 20090721 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX INC DATE OF NAME CHANGE: 19970710 D 1 primary_doc.xml X0707 D LIVE 0001042074 CymaBay Therapeutics, Inc. 7999 GATEWAY BLVD SUITE 130 NEWARK CA CALIFORNIA 94560 510-293-8800 DELAWARE METABOLEX, INC. METABOLEX INC Corporation true Harold Van Wart, Ph. D. 7999 Gateway Blvd., Suite 130 Newark CA CALIFORNIA 94560 Executive Officer Director Charles A. McWherter, Ph. D. 7999 Gateway Blvd., Suite 130 Newark CA CALIFORNIA 94560 Executive Officer Sujal Shah 7999 Gateway Blvd., Suite 130 Newark CA CALIFORNIA 94560 Executive Officer Louis G. Lange, M.D., Ph.D. 7999 Gateway Blvd., Suite 130 Newark CA CALIFORNIA 94560 Director Kurt von Emster 7999 Gateway Blvd., Suite 130 Newark CA CALIFORNIA 94560 Director Carl Goldfischer, M.D. 7999 Gateway Blvd., Suite 130 Newark CA CALIFORNIA 94560 Director Hari Kumar, Ph.D. 7999 Gateway Blvd., Suite 130 Newark CA CALIFORNIA 94560 Director Robert J. Wills 7999 Gateway Blvd., Suite 130 Newark CA CALIFORNIA 94560 Director Pol Boudes 7999 Gateway Blvd., Suite 130 Newark CA CALIFORNIA 94560 Executive Officer Biotechnology Decline to Disclose 06b false 2015-08-07 false true true false 0 324999 324999 0 false 2 0 0 0 false CymaBay Therapeutics, Inc. /s/ Sujal Shah Sujal Shah Chief Financial Officer 2015-08-13